← Leaderboards
Steven L Teitelbaum
Washington University
$21,654,872
Attributed
$21,654,872
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$21,654,872 · 9
By mechanism
R01$18,345,075 · 8
R37$3,309,797 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Haibo Zhao$3,493,160
- Yousef Abu-Amer$14,085,490
- Katherine Nelson Weilbaecher$8,913,824
- Beth S. Lee$3,699,225
- Dipanjan Pan$1,633,276
Others in their field
Top investigators on “Osteoclasts”
- Brendan Hl Lee · Baylor College Of Medicine$18,789,257
- Mone Zaidi · Icahn School Of Medicine At Mount Sinai$16,089,949
- Karl Leonard Insogna · Yale University$15,344,415
- Yi-Ping Li · Tulane University Of Louisiana$14,733,549
- Yongwon Choi · University Of Pennsylvania$14,421,139
- Hong-Wen Deng · Father Flanagan'S Boys'Home$14,176,978
Research focus
OsteoclastsOsteoporosisMediatingSignal TransductionCytoskeletonBoneBone ResorptionCellsEventLaboratory MouseSkeletalIntegrinsOsteogenesisOsteolysisFundingMacrophage Colony-Stimulating FactorReceptorInflammatoryOsteoblastsComplexFractureGenetically Modified AnimalsProtein Structure FunctionLigands
Grant awards (57)
Hepatic steatosis promotes liver metastasis$492,873
R01 · FY2024 · CA · contact PI
Hepatic steatosis promotes liver metastasis$470,750
R01 · FY2023 · CA · contact PI
Hepatic steatosis promotes liver metastasis$457,219
R01 · FY2022 · CA · contact PI
FAT TALKS TO BONE$381,250
R01 · FY2021 · DK · contact PI
FAT TALKS TO BONE$381,250
R01 · FY2020 · DK · contact PI
FAT TALKS TO BONE$381,250
R01 · FY2019 · DK · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$335,500
R37 · FY2019 · AR · contact PI
FAT TALKS TO BONE$381,250
R01 · FY2018 · DK · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$335,500
R37 · FY2018 · AR · contact PI
FAT TALKS TO BONE$381,250
R01 · FY2017 · DK · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$335,500
R37 · FY2017 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$335,500
R37 · FY2016 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$335,500
R37 · FY2015 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$321,753
R37 · FY2014 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$311,904
R37 · FY2013 · AR · contact PI
Mechanisms of Polarized Secretion by Bone Cells$308,785
R01 · FY2013 · AR · contact PI
Mechanisms of RANKL Mediated Osteoclast Activation$513,043
R01 · FY2012 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$328,320
R37 · FY2012 · AR · contact PI
Mechanisms of Polarized Secretion by Bone Cells$325,037
R01 · FY2012 · AR · contact PI
Mechanisms of RANKL Mediated Osteoclast Activation$513,043
R01 · FY2011 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$328,320
R37 · FY2011 · AR · contact PI
Mechanisms of Polarized Secretion by Bone Cells$325,037
R01 · FY2011 · AR · contact PI
Mechanisms of RANKL Mediated Osteoclast Activation$520,164
R01 · FY2010 · AR · contact PI
CDC 42 BIM AND THE OSTEOCLAST$378,216
R01 · FY2010 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$342,000
R37 · FY2010 · AR · contact PI
MECHANISMS OF POLARIZED SECRETION BY BONE CELLS$338,580
R01 · FY2010 · AR · contact PI
Mechanisms of RANKL Mediated Osteoclast Activation$510,474
R01 · FY2009 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$483,185
R01 · FY2009 · AR · contact PI
Mechanisms of Rankl Mediated Osteoclast Activation$438,699
R01 · FY2009 · AR · contact PI
CDC 42 BIM AND THE OSTEOCLAST$380,000
R01 · FY2009 · AR · contact PI
MECHANISMS OF POLARIZED SECRETION BY BONE CELLS$342,000
R01 · FY2009 · AR · contact PI
Mechanisms of RANKL Mediated Osteoclast Activation$495,911
R01 · FY2008 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$472,274
R01 · FY2008 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$470,795
R01 · FY2007 · AR · contact PI
Mechanisms of Orthopedic Implant Osteolysis$597,730
R01 · FY2006 · AR · contact PI
Mechanisms of AVB3 Integrin Mediated Bone Resorption$473,891
R01 · FY2006 · AR · contact PI
RANK Ligand is a Bone Anabolic Agent$334,293
R01 · FY2006 · AR · contact PI
Mechanisms of Orthopedic Implant Osteolysis$23,887
R01 · FY2006 · AR · contact PI
Mechanisms of Orthopedic Implant Osteolysis$612,113
R01 · FY2005 · AR
Mechanisms of AVB3 Integrin Mediated Bone Resorption$481,561
R01 · FY2005 · AR
RANK Ligand is a Bone Anabolic Agent$342,338
R01 · FY2005 · AR
Mechanisms of Orthopedic Implant Osteolysis$636,814
R01 · FY2004 · AR
RANK Ligand is a Bone Anabolic Agent$371,025
R01 · FY2004 · AR
MECHANISMS OF AVB3 INTEGRIN MEDIATED BONE RESORPTION$352,940
R01 · FY2004 · AR
Mechanisms of Orthopedic Implant Osteolysis$495,376
R01 · FY2003 · AR
RANK Ligand is a Bone Anabolic Agent$371,025
R01 · FY2003 · AR
MECHANISMS OF AVB3 INTEGRIN MEDIATED BONE RESORPTION$198,175
R01 · FY2003 · AR
MECHANISMS OF AVB3 INTEGRIN MEDIATED BONE RESORPTION$135,799
R01 · FY2003 · AR
Mechanisms of Orthopedic Implant Osteolysis$111,338
R01 · FY2003 · AR
Mechanisms of Orthopedic Implant Osteolysis$598,148
R01 · FY2002 · AR
RANK Ligand is a Bone Anabolic Agent$349,093
R01 · FY2002 · AR
MECHANISMS OF AVB3 INTEGRIN MEDIATED BONE RESORPTION$308,123
R01 · FY2002 · AR
MECHANISMS OF AVB3 INTEGRIN MEDIATED BONE RESORPTION$301,658
R01 · FY2001 · AR
MECHANISMS OF ORTHOPEDIC IMPLANT OSTEOLYSIS$269,695
R01 · FY2001 · AR
MECHANISMS OF AVB3 INTEGRIN MEDIATED BONE RESORPTION$295,383
R01 · FY2000 · AR
BONE RESORPTION IN PERIODONTAL DISEASE$279,629
R01 · FY2000 · DE
MECHANISMS OF ORTHOPEDIC IMPLANT OSTEOLYSIS$262,706
R01 · FY2000 · AR